Efficacy of dexmedetomidine as an adjuvanct to ropivacaine in pediatric caudal epidural block

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20111102007984N30

Enrollment

Registered

2019-10-05

Start date

2018-12-21

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain. Other acute postprocedural pain

Interventions

Intervention 1: Intervention group: First group will receive ropivacaine 0.2%, 1.5 mg/kg (maximum 25 mg) before extubation. Intervention 2: Intervention group: The second group will receive ropivacain

Eligibility

Sex/Gender

All

Age

3 Years to 10 Years

Inclusion criteria

Inclusion criteria: ASA class I or II Lower abdomen and epigastric surgeries like hernia and UDT Surgery time between 30 minutes and 2 hours No sensitivity to dexmedetomidine and ropivacaine

Exclusion criteria

Exclusion criteria: Complicated surgeries (long or bleeding in need of transfusion) Parents do not give consent for their children to participate

Design outcomes

Primary

Measure	Time frame
Postoperative pain. Timepoint: One, two and till 6 hours after surgery. Method of measurement: Using Modified Children’s Hospital of Eastern Ontario Pain Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnad Imani

Iran University of Medical Sciences

farnadimani@yahoo.com+98 21 6651 5758

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026